Simon Witty
Lawyers
Filters
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
ACG Metals de-SPAC transaction to acquire the Gediktepe mine in Turkey
The shares are listed on the London Stock Exchange
Royalty Pharma $1.5 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
LivaNova $345 million convertible notes offering and capped call transactions
The 2.5% convertible senior notes are due 2029
Immunocore Holdings $402.5 million convertible notes offering
The 2.5% convertible notes are due 2030
Arm $4.87 billion IPO
The deal is the largest U.S. IPO since November 2021
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
New Energy One Acquisition £175 million IPO
Shares of the SPAC are listed on the London Stock Exchange
LivaNova $345 million equity offering
We advised the underwriters on the SEC-registered offering